Effects of Kampo Medicines (oren-to) for oral mucositis in patients receiving radiation therapy

Phase 4

Recruiting

• Conditions: oral mucositis; Radiation therapy, anticancer drugs; D013280

• Registration Number: JPRN-jRCT1031190210
• Lead Sponsor: amiki Takao

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients receiving radiation therapy (60Gy) combined with anti-cancer medication (cisplatin) for head and neck cancer (oral, oro- and hypo-pharyngeal cancer)

Exclusion Criteria

1. Patient who cannot take Kampo medications at start of this research
2. Patient with allergy for oren-to
3. Patient who is judged to be inappropriate to carry out the research safely by the principal or sub investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified